Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.

[1]  S. Shibata,et al.  Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[2]  A. Sendelhofert,et al.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. , 1998, The American journal of pathology.

[3]  Sekine,et al.  Inducible nitric oxide synthase is expressed in granuloma pyogenicum , 1998, The British journal of dermatology.

[4]  Masahiro Ito,et al.  Expression of Ets-1 transcription factor in relation to angiogenesis in the healing process of gastric ulcer. , 1998, Biochemical and biophysical research communications.

[5]  J. Mohler,et al.  Downregulation of the β4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia , 1998 .

[6]  J. Fagin,et al.  Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.

[7]  K. Tanikawa,et al.  Coordinated expression of integrin α6β1 and laminin in hepatocellular carcinoma , 1997 .

[8]  M. Wassef,et al.  Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. , 1997, The American journal of pathology.

[9]  Y. Otani,et al.  Difference in gene expression for matrix metalloproteinase‐1 between early and advanced hepatocellular carcinomas , 1997, Hepatology.

[10]  Y. Okada,et al.  Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. , 1996, Cancer research.

[11]  M. Abe,et al.  Ets‐1 regulates angiogenesis by inducing the expression of urokinase‐type plasminogen activator and matrix metalloproteinase‐1 and the migration of vascular endothelial cells , 1996, Journal of cellular physiology.

[12]  J. Fagin,et al.  Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. , 1996, The American journal of pathology.

[13]  V. Gouyer,et al.  Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. , 1995, The American journal of pathology.

[14]  T. Noumi,et al.  Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.

[15]  B. Vandenbunder,et al.  Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.

[16]  R. J. Fisher,et al.  An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. , 1994, The Journal of biological chemistry.

[17]  P. Verde,et al.  A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. , 1992, The EMBO journal.

[18]  P. Rørth,et al.  Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. , 1991, Oncogene.

[19]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[20]  A. Seth,et al.  The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. , 1990, Oncogene.

[21]  B. Wasylyk,et al.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.

[22]  B. Wasylyk,et al.  The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.

[23]  N. Bhat,et al.  Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. , 1990, Oncogene.

[24]  L. Liotta,et al.  Metalloproteinases and cancer invasion. , 1990, Seminars in cancer biology.

[25]  J. Ghysdael,et al.  The c-ets-1 protein is chromatin associated and binds to DNA in vitro. , 1989, Oncogene.

[26]  S. Nagataki,et al.  Analysis of alpha‐fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization , 1988, Cancer.

[27]  J. Brooks,et al.  Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors. , 1988, The American journal of pathology.

[28]  N. Bhat,et al.  Characterization and localization of the products of the human homologs of the v-ets oncogene. , 1988, Oncogene.

[29]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  U. Mohr,et al.  [Tumors of vascular tissues]. , 1971, Zahnarztliche Praxis.

[31]  J. Dittmer,et al.  Regulation of Parathyroid Hormone-related Protein (PTHrP) Gene Expression AN AND REGULATES PROMOTER ACTMTY IN COOPERATION WITH Etsl* , 2001 .

[32]  I. Sekine,et al.  Expression of the ets-1 proto-oncogene in human thyroid tumor. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[33]  B. Vandenbunder,et al.  Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? , 1994, Folia biologica.

[34]  J. Brooks,et al.  Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[35]  B. Vandenbunder,et al.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. , 1992, The American journal of pathology.